Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches
Oncolytic virotherapy is a type of nanomedicine with a dual antitumor mechanism. Viruses are engineered to selectively infect and lyse cancer cells directly, leading to the release of soluble antigens which induce systemic antitumor immunity. Representative drug Talimogene laherparepvec has showed p...
Saved in:
Main Authors: | Qing Ji (Author), Yuchen Wu (Author), Andreas Albers (Author), Meiyu Fang (Author), Xu Qian (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progress of oncolytic virotherapy for neuroblastoma
by: Xiao-Tong Chen, et al.
Published: (2022) -
The combination therapy of oncolytic virotherapy
by: Yue Wang, et al.
Published: (2024) -
Current Status and Challenges of Oncolytic Virotherapy for the Treatment of Glioblastoma
by: Mason J. Webb, et al.
Published: (2023) -
Talimogene laherparepvec: First in class oncolytic virotherapy
by: Robert M. Conry, et al.
Published: (2018) -
A bibliometric analysis of oncolytic virotherapy combined with immunotherapy
by: Ting Zhang, et al.
Published: (2024)